Biochemical abnormalities in cerebrotendinous xanthomatosis
- PMID: 1817043
- DOI: 10.1159/000112186
Biochemical abnormalities in cerebrotendinous xanthomatosis
Abstract
Cerebrotendinous xanthomatosis (CTX) is a rare recessive inherited lipid storage disease that was first described by Van Bogaert. Although the principal clinical presentation affects the nervous system with dementia, spinal cord paresis, cerebellar ataxia and peripheral neuropathy, the liver is is the organ where the major biochemical abnormalities are expressed. The following sections deal with the pathogenesis and treatment of the biochemical problems in CTX.
Similar articles
-
Cerebrotendinous xanthomatosis as a multisystem disease mimicking premature ageing.Dev Neurosci. 1991;13(4-5):371-6. doi: 10.1159/000112187. Dev Neurosci. 1991. PMID: 1817044 Review.
-
Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.N Engl J Med. 1984 Dec 27;311(26):1649-52. doi: 10.1056/NEJM198412273112601. N Engl J Med. 1984. PMID: 6504105
-
[Cerebrotendinous xanthomatosis].Zh Nevropatol Psikhiatr Im S S Korsakova. 1992;92(4):13-22. Zh Nevropatol Psikhiatr Im S S Korsakova. 1992. PMID: 1333699 Russian.
-
Cerebrotendinous xanthomatosis is treatable.Pediatr Dermatol. 1985 Jul;2(4):294-6. doi: 10.1111/j.1525-1470.1985.tb00468.x. Pediatr Dermatol. 1985. PMID: 3925446
-
Cerebrotendinous xanthomatosis: a rare disease with diverse manifestations.Arch Neurol. 2002 Apr;59(4):527-9. doi: 10.1001/archneur.59.4.527. Arch Neurol. 2002. PMID: 11939886 Review.
Cited by
-
Pathophysiology and Treatment of Lipid Abnormalities in Cerebrotendinous Xanthomatosis: An Integrative Review.Brain Sci. 2023 Jun 22;13(7):979. doi: 10.3390/brainsci13070979. Brain Sci. 2023. PMID: 37508912 Free PMC article. Review.
-
Epidemiology, diagnosis, and treatment of cerebrotendinous xanthomatosis (CTX).J Inherit Metab Dis. 2017 Nov;40(6):771-781. doi: 10.1007/s10545-017-0093-8. Epub 2017 Oct 4. J Inherit Metab Dis. 2017. PMID: 28980151 Review.
-
Pharmacy Compounded Medicines for Patients With Rare Diseases: Lessons Learned From Chenodeoxycholic Acid and Cholic Acid.Front Pharmacol. 2021 Sep 28;12:758210. doi: 10.3389/fphar.2021.758210. eCollection 2021. Front Pharmacol. 2021. PMID: 34650439 Free PMC article.
-
Psychiatric manifestations in cerebrotendinous xanthomatosis.Transl Psychiatry. 2013 Sep 3;3(9):e302. doi: 10.1038/tp.2013.76. Transl Psychiatry. 2013. PMID: 24002088 Free PMC article. Review.
-
Lipids in the Physiopathology of Hereditary Spastic Paraplegias.Front Neurosci. 2020 Feb 28;14:74. doi: 10.3389/fnins.2020.00074. eCollection 2020. Front Neurosci. 2020. PMID: 32180696 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical